Skip to content
Clinical Trials – home

Gyneko spol. s.r.o.

Research site

Czechia Smetanova 954, 755 01 Vsetin, Czechia

  • Contraception · Hot flush
  • Adult patients

About Specializations

Gyneko spol. s.r.o. in Vsetin, Czechia specialises in clinical trials of conditions such as Contraception, Hot flush, and other specialisations. This site conducts important research.

Main research areas of the site

Hormonal Diseases and Reproductive Health Research

At Gyneko spol. s.r.o. in Vsetin, clinical research is focused on hormonal diseases and reproductive and urinary physiological phenomena. The studies center on improving care for women dealing with moderate to severe vasomotor symptoms and on evaluating options for pregnancy prevention.

  • Research on easing hot flashes and related symptoms in women affected by hormone-related breast cancer treatment
  • Clinical evaluation of a new approach to reduce the frequency and severity of vasomotor symptoms
  • Assessment of contraceptive efficacy and tolerability for a vaginal hormone-based delivery system

These trials aim to support better symptom control and more reliable contraceptive care, helping expand treatment choices in women’s health.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Smetanova 954755 01 VsetinCzechia
Recruiting now
no trials
Conditions studied
2

More sites in VsetinCzechia

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Contraception

Not recruiting

Study on the Effectiveness and Safety of Levonorgestrel Vaginal Delivery System vs. Desogestrel Tablets for Preventing Pregnancy in Women

Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · Healthy volunteers
  • Substances:Desogestrel
  • Sponsor:Chemo Research S.L.

Hot flush

Not recruiting

Study of Fezolinetant for Hot Flashes in Women with Hormone Receptor-Positive Breast Cancer Receiving Hormone Therapy

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Fezolinetant
  • Sponsor:Astellas Pharma Global Development Inc.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.